肝细胞癌诊断与治疗路线图(修订版)

2012-06-26 MedSci MedSci原创

  近日,华中科技大学同济医学院附属同济医院陈孝平、张志伟执笔编写的《肝细胞癌诊断与治疗路线图(修订版)》刊登在2012年6月份出版的《中华外科杂志》上。   《肝细胞癌诊断与治疗路线图(修订版)》由中华医学会外科学分会肝脏外科学组制定,是在2010年的版本的更新版。据悉,2010年《腹部外科》刊发的华中科技大学附属同济医院肝脏外科陈孝平教授主持制定的《肝细胞癌诊断与治疗路线图》得到积极反响。根

http://pic2.cmt.com.cn/WebImages/23821/23821_2dbe93a0-2ef5-4d66-856d-0bb3cf168f95.jpg

  近日,华中科技大学同济医学院附属同济医院陈孝平、张志伟执笔编写的《肝细胞癌诊断与治疗路线图(修订版)》刊登在2012年6月份出版的《中华外科杂志》上。

  《肝细胞癌诊断与治疗路线图(修订版)》由中华医学会外科学分会肝脏外科学组制定,是在2010年的版本的更新版。据悉,2010年《腹部外科》刊发的华中科技大学附属同济医院肝脏外科陈孝平教授主持制定的《肝细胞癌诊断与治疗路线图》得到积极反响。根据广大读者的反馈意见,经陈孝平教授提议,中华医学会外科学分会肝脏外科学组全体委员以及有关专家对《肝细胞癌诊断与治疗路线图》进行了讨论、修订。

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=145031, encodeId=58dc1450318b, content=这个值得看, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Tue Oct 11 19:19:10 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978327, encodeId=0d6019e8327ba, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Oct 24 00:23:00 CST 2012, time=2012-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719000, encodeId=0e2f1e19000e3, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Sun Jan 06 01:23:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863193, encodeId=70381863193d3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Apr 30 12:23:00 CST 2013, time=2013-04-30, status=1, ipAttribution=)]
    2016-10-11 1e128d2fm65(暂无匿称)

    这个值得看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=145031, encodeId=58dc1450318b, content=这个值得看, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Tue Oct 11 19:19:10 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978327, encodeId=0d6019e8327ba, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Oct 24 00:23:00 CST 2012, time=2012-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719000, encodeId=0e2f1e19000e3, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Sun Jan 06 01:23:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863193, encodeId=70381863193d3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Apr 30 12:23:00 CST 2013, time=2013-04-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=145031, encodeId=58dc1450318b, content=这个值得看, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Tue Oct 11 19:19:10 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978327, encodeId=0d6019e8327ba, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Oct 24 00:23:00 CST 2012, time=2012-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719000, encodeId=0e2f1e19000e3, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Sun Jan 06 01:23:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863193, encodeId=70381863193d3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Apr 30 12:23:00 CST 2013, time=2013-04-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=145031, encodeId=58dc1450318b, content=这个值得看, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Tue Oct 11 19:19:10 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978327, encodeId=0d6019e8327ba, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Oct 24 00:23:00 CST 2012, time=2012-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1719000, encodeId=0e2f1e19000e3, content=<a href='/topic/show?id=e32e915e89c' target=_blank style='color:#2F92EE;'>#诊断与治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91578, encryptionId=e32e915e89c, topicName=诊断与治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85a832689492, createdName=木头人524, createdTime=Sun Jan 06 01:23:00 CST 2013, time=2013-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863193, encodeId=70381863193d3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Tue Apr 30 12:23:00 CST 2013, time=2013-04-30, status=1, ipAttribution=)]
    2013-04-30 xjy02

相关威廉亚洲官网

[EASL2012]中国单元——“三首”亮相欧肝会

       【前言】第47届欧洲肝病研究学会年会,暨2012年国际肝脏大会,开幕的首日由中国北京大学医学部庄辉院士和EASL科学委员会成员、意大利亚历山德罗·曼佐尼医院(Ospedale Alessandro Manzoni)丹尼尔·普拉蒂(Daniele Prati)教授共同担任主持的“EASL-CHINA NETWORK”,成为此次

[EASL2012]NAFLD——肝细胞癌的隐匿危险因素

       全新证据显示,肝细胞肝癌(HCC)合并非酒精性脂肪性肝病(NAFLD)日益常见。第47届欧洲肝脏研究协会(EASL)年会,暨2012国际肝脏大会上,来自英国纽卡斯尔大学的H. Reeves教授为williamhill asia 带来了一项大型多中心队列研究的结果,该研究显示:NAFLD相关性HCC患者常无肝硬化,尽管有临床症状,但通常肝功能处于代偿期,且

Cancer Res.:AMPK调节p53抑制肝细胞癌

6月22日,Cancer Research 杂志报道了AMP活化的蛋白激酶(AMPK)自身在肝细胞癌中发挥抑癌功能的机制研究。 AMP活化的蛋白激酶(AMPK),一个细胞能量状态的生物感应器,已被证明在已知的肿瘤抑制基因的上游和下游发挥作用。然而,是否AMPK本身起着肿瘤抑制因子的作用仍不清楚。 该研究发现, AMPK的α2催化亚基异构体在肝细胞癌(HCC)中显著下调。临床分析表明,AMPK-

HBx与AIB1协同加速肝细胞癌进程

文献标题:Hepatitis B virus X protein stabilizes AIB1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness 文献来源:Hepatology. 2012 Apr 2. 期刊影响因子:10.885   

Gastroenterology:HBsAg水平可预测乙肝相关性肝细胞癌风险

文献标题:High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load. 文献出处:Gastroenterology. 2012 Feb 11. 期刊影响因子:12.032